Additionally, we hypothesized that patients with undiagnosed OSA would show increased circulating levels of IL-6 and therefore, would have an increased risk of metabolic, pulmonary, and neurocognitive sequelae. The gene discussed is IL6; the disease is obstructive sleep apnea syndrome.